Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,409
  • Shares Outstanding, K 47,241
  • Annual Sales, $ 104,710 K
  • Annual Income, $ -10,320 K
  • 60-Month Beta 1.33
  • Price/Sales 1.18
  • Price/Cash Flow N/A
  • Price/Book 1.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +2.39%
on 03/15/19
3.65 -29.59%
on 02/25/19
-0.94 (-26.78%)
since 02/22/19
3-Month
2.32 +10.78%
on 12/26/18
4.13 -37.77%
on 02/11/19
+0.06 (+2.39%)
since 12/21/18
52-Week
2.32 +10.78%
on 12/26/18
6.89 -62.70%
on 05/18/18
-3.40 (-56.95%)
since 03/22/18

Most Recent Stories

More News
Enzo Biochem: Fiscal 2Q Earnings Snapshot

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a loss of $8.4 million in its fiscal second quarter.

ENZ : 2.57 (-1.53%)
Enzo Biochem Reports Second Fiscal Quarter and First Half 2019 Results and Reports Progress on Its Investments and Strategic Goals

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company,today reported results for the fiscal quarter and first half ended January 31, 2019 along with providing...

ENZ : 2.57 (-1.53%)
Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2019 Results Tuesday, March 12, 2019 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2019 second quarter results Tuesday, March 12, 2019, at 8:30 AM E.T.

ENZ : 2.57 (-1.53%)
Enzo Biochem: Fiscal 1Q Earnings Snapshot

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a loss of $6 million in its fiscal first quarter.

ENZ : 2.57 (-1.53%)
Enzo Biochem Reports Fiscal 2019 First Quarter Results

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today reported operating results for the first fiscal quarter ended October 31, 2018, in addition to providing...

ENZ : 2.57 (-1.53%)
Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, will hold a conference call to discuss fiscal 2019 first quarter results Tuesday, December 11, 2018,...

ENZ : 2.57 (-1.53%)
Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today reported the publication of a study in the Journal of Lipid Research by researchers at a collaborating...

ENZ : 2.57 (-1.53%)
Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case

Enzo Biochem, Inc. (NYSE:ENZ) and its subsidiary Enzo Life Sciences, Inc. today announced that the Patent Trial and Appeal Board has denied a petition filed by Hologic, Inc. (NASDAQ:HOLX)...

ENZ : 2.57 (-1.53%)
HOLX : 46.85 (-1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ENZ with:

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

2nd Resistance Point 2.70
1st Resistance Point 2.63
Last Price 2.57
1st Support Level 2.52
2nd Support Level 2.48

See More

52-Week High 6.89
Fibonacci 61.8% 5.14
Fibonacci 50% 4.61
Fibonacci 38.2% 4.07
Last Price 2.57
52-Week Low 2.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar